Old Web
English
Sign In
Acemap
>
authorDetail
>
Elisa Calcagno
Elisa Calcagno
Columbia University Medical Center
Cancer research
Medicine
Lymphoma
Romidepsin
Histone
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Strategy for Overcoming Crebbp and EP300 Mutations in Lymphoma: Development of First-in-Class HAT Activators
2019
Blood
Yuxuan Liu
Jole Fiorito
Yulissa Gonzalez
Brian Estrella
Elisa Calcagno
Elisa Zuccarello
Howook Hwang
Barry Honig
Shixian Deng
Donald W. Landry
Owen A. O'Connor
Ottavio Arancio
Jennifer E. Amengual
Show All
Source
Cite
Save
Citations (0)
FIRST-IN-CLASS HAT ACTIVATOR HIGHLY SYNERGISTIC WITH PAN-HDAC INHIBITOR ROMIDEPSIN LEADING TO PROFOUND HISTONE ACETYLATION CYTOTOXICITY
2019
Hematological Oncology
Yuxuan Liu
J. Fiorito
Y. Gonzale
Elisa Zuccarello
Elisa Calcagno
Jeannie M. Camarillo
Paul M. Thomas
Neil L. Kelleher
Shixian Deng
Donald W. Landry
Owen A. O'Connor
A. J. Wolfe
B. Moyer
Ottavio Arancio
Jennifer E. Amengual
Show All
Source
Cite
Save
Citations (1)
Development of First-in-Class Histone Acetyltransferase (HAT) Activators for Precision Targeting of Epigenetic Derangements in Lymphoma
2018
Blood
Yuxuan Liu
Jole Fiorito
Yulissa Gonzalez
Elisa Zuccarello
Elisa Calcagno
Adolfo Mazzeo
Nebiyu Abshiru
Jeannie M. Camarillo
Neil L. Kelleher
Changhong Qiao
Renu Nandakumar
Cremers Serge
Shixian Deng
Donald W. Landry
Owen A. OConnor
Ottavio Arancio
Jennifer E. Amengual
Show All
Source
Cite
Save
Citations (1)
1